• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2002726 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Supplementary Application 2021-01-01 阿斯利康制药有限公司 Astrazeneca Pharmaceutical Co Ltd;Ironwood Pharmaceuticals Inc;Almac Pharma Services Ltd Filed 2021-01-15 view
JYHB2002694 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Supplementary Application 2020-12-28 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Ironwood Pharmaceuticals Inc;Almac Pharma Services Ltd In Review 2020-12-25 view
JYHB2002693 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Supplementary Application 2020-12-28 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Ironwood Pharmaceuticals Inc;Almac Pharma Services Ltd In Review 2020-12-25 view
JYHB2002063 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Supplementary Application 2020-10-16 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Ironwood Pharmaceuticals Inc;Almac Pharma Services Ltd Filed 2020-11-05 view
JYHB2000487 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Supplementary Application 2020-04-26 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Ironwood Pharmaceuticals Inc;Almac Pharma Services Ltd Certificate Issued 2020-07-23 view
JYHF2000048 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Supplementary Application 2020-05-06 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Ironwood Pharmaceuticals Inc;Almac Pharma Services Ltd Certificate Issued 2020-05-26 view
JYHB1900252 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Supplementary Application 2019-02-27 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Ironwood Pharmaceuticals Inc;Almac Pharma Services Ltd Certificate Issued 2019-07-16 view
JYHB1900174 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Supplementary Application 2019-02-22 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Ironwood Pharmaceuticals Inc;Almac Pharma Services Ltd Certificate Issued 2019-03-21 view
JYHB1900125 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Supplementary Application 2019-01-29 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Ironwood Pharmaceuticals Inc;Almac Pharma Services Ltd Filed 2019-02-13 view
JXHL1600007 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Import Drug Application 2016-01-21 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Ironwood Pharmaceuticals Inc Certificate Issued 2019-01-15 view
JXHL1600006 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Import Drug Application 2016-01-31 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Ironwood Pharmaceuticals Inc Certificate Issued 2019-01-15 view
JYHB2300133 利那洛肽胶囊 linaclotide Capsule Chemical Drugs Supplementary Application 2023-02-21 Almac Pharma Services Ltd;AstraZeneca AG view
CYHS2302540 利那洛肽胶囊 linaclotide Capsule Chemical Drugs(4) Generic Drug 2023-09-20 Jiangsu Feima Pharmaceutical Co Ltd;Suzhou Tianma PHARMA Group Tianji BIO-PHARMACEUTICAL Co Ltd view
CYHS2500805 利那洛肽胶囊 linaclotide Capsule Chemical Drugs(4) Generic Drug 2025-02-20 Jiangxi Kerui Pharmaceutical Co Ltd view
CYHL2300023 利那洛肽胶囊 linaclotide Capsule Chemical Drugs(4) Generic Drug 2023-02-18 Hybio Pharmaceutical Co Ltd view
JYHZ2300221 利那洛肽胶囊 linaclotide Capsule Chemical Drugs License Renew 2023-05-11 Almac Pharma Services Ltd;Astrazeneca Investment (China) Co Ltd;AstraZeneca AG view
CYHS2403816 利那洛肽胶囊 linaclotide Capsule Chemical Drugs(4) Generic Drug 2024-11-08 Chengdu Shengnuo Biopharm Co Ltd view
CYHS2201778 利那洛肽胶囊 linaclotide Capsule Chemical Drugs(4) Generic Drug 2022-10-19 Double-Crane Pharmaceutical(Hainan) Co Ltd view
JYHZ2300222 利那洛肽胶囊 linaclotide Capsule Chemical Drugs License Renew 2023-05-11 Almac Pharma Services Ltd;Astrazeneca Investment (China) Co Ltd;AstraZeneca AG view
CYHS2403534 利那洛肽胶囊 linaclotide Capsule Chemical Drugs(4) Generic Drug 2024-10-18 Hubei Minkang Pharmaceutical Group Co Ltd;Nanjing Healthnice Pharmaceutical Co Ltd view